Skip to main content
Top
Published in: Journal of Neurology 3/2021

01-03-2021 | Spinal Cord Stimulation | Original Communication

Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients

Authors: Olivia Samotus, Andrew Parrent, Mandar Jog

Published in: Journal of Neurology | Issue 3/2021

Login to get access

Abstract

Background

There are no effective symptomatic treatments for progressive supranuclear palsy (PSP). Recent studies report benefits of spinal cord stimulation (SCS) for freezing of gait (FOG) and gait disorders in Parkinson’s disease and atypical Parkinsonism patients. This is the first study to report therapeutic effects of SCS in Richardson’s syndrome PSP (PSP-RS) patients.

Methods

Epidural SCS was implanted in three female PSP-RS participants (3.2 ± 1.3 years with disease). Six programs (300–400 µs/30–130 Hz) were randomly tested at suprathreshold intensity on separate days. The setting that best improved gait/FOG was used daily by each participant in the study. Protokinetics walkway captured spatiotemporal gait measures and FOG episodes (turning on the spot and while walking) and clinical scales including FOG questionnaire, UPDRS-III (OFF-/ON-l-dopa), and participant-perceived global impression of change (GISC) were collected at pre-SCS, and 3, 6, 12 months post-SCS.

Results

Participant #1 demonstrated the highest GISC score (6.5/10) with a consistent reduction of FOGs by 43.8%, UPDRS-III score (− 5 points), and improved step length and stride velocity (33.6%) while maintaining a l-dopa response of ~ 12% over the 12 months. Participant #2, walking FOG frequency and turning duration was reduced by 39.0% (OFF-l-dopa), and ON-l-dopa UPDRS-III score worsened (+ 5 points) at 12 months. Participant #3, FOG frequency reduced by 75% up to 6 months rating a GISC 3/10 score, however disease severity worsened at 12 months. Ambulatory gait parameters universally improved by 29.6% in all participants.

Conclusion

The results support the benefit of SCS for FOG and gait symptoms in PSP-RS and suggests early SCS intervention for dopaminergic-resistant gait should be considered.
Literature
18.
go back to reference de Souza CP, Hamani C, Oliveira Souza C, Lopez Contreras WO, Dos Santos Ghilardi MG et al (2017) Spinal cord stimulation improves gait in patients with Parkinson’s disease previously treated with deep brain stimulation. Mov Disord Off J Mov Disord Soc 32:278–282. https://doi.org/10.1002/mds.26850CrossRef de Souza CP, Hamani C, Oliveira Souza C, Lopez Contreras WO, Dos Santos Ghilardi MG et al (2017) Spinal cord stimulation improves gait in patients with Parkinson’s disease previously treated with deep brain stimulation. Mov Disord Off J Mov Disord Soc 32:278–282. https://​doi.​org/​10.​1002/​mds.​26850CrossRef
24.
go back to reference Yearwood TL, Hershey B, Bradley K, Lee D (2010) Pulse width programming in spinal cord stimulation: a clinical study. Pain Phys 13:321–335 Yearwood TL, Hershey B, Bradley K, Lee D (2010) Pulse width programming in spinal cord stimulation: a clinical study. Pain Phys 13:321–335
Metadata
Title
Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients
Authors
Olivia Samotus
Andrew Parrent
Mandar Jog
Publication date
01-03-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 3/2021
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-10233-7

Other articles of this Issue 3/2021

Journal of Neurology 3/2021 Go to the issue